All articles are linked to PubMed where available.
If you are interested in re-prints of any articles, please contact pr@austrianova.com with the details.
2005 onwards
2000 – 2004
1999 |
| Pelegrin, M., Noel, D., Saller, R.M., Salmons, B. and Piechaczyk, M. (1999) Encapsulated antibody-producing cells for long-term passive immunotherapy. Pharmaceutical Technology 23, 46-49 (also BioPharm 12, 32-35) |
| Muller, P., Jesnowski, R., Karle, P., Renz, R., Saller, R., Stein, H., Puschel, K., von Rombs, K., Nizze, H., Liebe, S., Wagner, T., Günzburg, W.H., Salmons, B., Lohr, M. (1999) Injection of encapsulated cells producing an ifosfamide-activating cytochrome P450 for targeted chemotherapy to pancreatic tumors. Annals of New York Academy of Science 880, 337-351 |
| Kröger, J.C., Bergmeister, H., Hoffmeyer, A., Ceijna, M., Karle, P., Saller, R., Schwendenwein, I., von Rombs, K., Liebe, S., Günzburg, W.H., Salmons, B., Hauenstein, K-H., Losert, U. and Löhr, M. (1999) Intra-arterial instillation of microencapsulated cells in the pancreatic arteries in pig. Annu. N. Y. Acad. Sci. 880, 374-378 |
| Günzburg, W.H., Karle, P., Renz, R., Salmons, B. and Renner, M. (1999) Characterisation of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy. Annu. N. Y. Acad. Sci. 880, 326-336 |
| Löhr, J.M., Bago, Z.T., Bergmeister, H., Ceijka, M., Freund, M., Gelbmann, W., Günzburg, W.H., Hain, J., Hauenstein, K., Henniger, W., Hoffmeyer, A., Karle, P., Kröger, J-C., Liebe, S., Losert, U., Probst, A., Renner, M., Renz, R., Saller, R., Salmons, B., Schuh, M., Wagner, T. and Walter, I. (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced stage pancreatic carcinoma: phase I/II study. Journal of Molecular Medicine. 77, 393-398 |
| Dautzenberg, H., Schuldt, U., Grasnick, G., Karle, P., Müller, P., Löhr, M., Pelegrin, M., Piechaczyk, M., von Rombs, K., Günzburg, W.H., Salmons, B. and Saller, R.M. (1999) Development of cellulose sulphate based polyelectrolyte complex microcapsules for medical applications. (Bioartificial Organs II: Technology, Medicine & Materials. Eds. Hunkeler, D., Prokop, A., Cherrrington, A.D., Rajotte, R. and Sefton, M.) Annu. N.Y. Acad. Sci. 875, 46-63 |
| Pelegrin, M., Noel, D., Marin, M., Bachrach, E., Saller, R.M., Salmons, B. and Piechaczyk, M. (1999) In vivo production of therapeutic antibodies by engineered cells for immunotherapy of cancer and viral diseases. Gene Ther. Mol. Biol. 3, 167-177 |
1998 |
| Pelegrin, M., Marin, M., Noël, D., Del Rio, M., Saller, R., Stange, J., Mitzner, S., Günzburg, W.H. and Piechaczyk, M. (1998) Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Therapy 5, 828-834 |
| Karle, P., Müller, P., Renz, R., Jesnowski, R., Saller, R.M., von Rombs, K., Nizze, H., Liebe, S., Günzburg, W.H., Salmons, B and Löhr, M. (1998) Intratumour injection of encapsulated cells producing an ifosfamide activating cytochrome P450 for targeted chemotherapy. Adv. Exp. Med. Biol. 451, 97-106 |
| Löhr, M., Müller, P., Karle, P., Stange, J., Mitzner, S., Jesnowski, R., Nizze, H., Nebe, B., Liebe, S., Salmons, B. and Günzburg, W.H. (1998) Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450. Gene Therapy 5, 1070-1078 |
